Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediNippon is a Japan-based Contract Research Organization (CRO) and regulatory consulting firm that specializes in facilitating the entry of foreign pharmaceutical and medical device companies into the Japanese market. The company provides a comprehensive suite of services, including regulatory affairs consulting, clinical trial management, and post-marketing surveillance. MediNippon often acts as an In-Country Clinical Care-taker (ICCC) for international sponsors, navigating the complex requirements of the Pharmaceuticals and Medical Devices Agency (PMDA). Their expertise spans across various therapeutic areas, helping clients bridge the gap between global development programs and Japanese regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medinippon.